Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis

Journal of Hepatology

Volumn 27, Issue 2, 1997, Pages 331-336

  Naoumov, Nikolai V ^a   Chokshi, Shilpa ^a   Metivier, Elizabeth ^a   Maertens, Geert ^b   Johnson, Philip J ^a   Williams, Roger ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b INNOGENETICS   (Belgium)

Author keywords

Cirrhosis; HCV genotypes; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

VIRUS RNA;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS STRAIN;

EID: 0030807167     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80179-1     Document Type: Article

References (34)

1. Johnson PJ, Williams R. Cirrhosis and etiology of hepatocellular carcinoma. J Hepatol. 4:1987;140-147.
2. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 61:1988;1942-1956.
3. Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet. ii:1989;1006-1008.
4. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma. Lancet. ii:1989;1004-1006.
5. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, et al. Hepatitis C virus infection is associated with the development of hepatocelluar carcinoma. Proc Natl Acad Sci USA. 87:1990;6547-6549.
6. Liang TJ, Jeffers L, Reddy KR, Medina MD, Parker IT, Cheinquer H, et al. Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology. 18:1993;1326-1333.
7. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 12:1990;671-675.
8. DiBisceglie AM, Simpson LH, Lotze MT, Hoofnagle JH. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C virus infection. J Clin Gastroenterol. 19:1994;222-226.
9. Tong MJ, El-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 332:1995;1463-1466.
10. Melia W, Wilkinson M, Portmann B, Johnson PJ, Williams R. Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis. Q J Med. 211:1984;391-400.
11. Kew M, Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis. 4:1984;136-145.
12. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology. 15:1992;948-963.
13. Simmonds P. Variability of hepatitis C virus. Hepatology. 21:1995;570-583.
14. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takanayagi M, Higashi Y, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology. 16:1992;293-299.
15. Dusheiko G, Schmilovitzweiss H, Brown D, McOmish F, Yap PL, Sherlock S, et al. Hepatitis C virus genotypes - an investigation of type specific differences in geographic origin and disease. Hepatology. 19:1994;13-18.
16. Nousbaum J-B, Pol S, Nalpas B, Landais, Barthelot P, Brechot C, et al. Hepatitis C virus type 1b(II) infection in France and Italy. Ann Intern Med. 122:1995;161-168.
17. Zaman SN, Melia WM, Johnson RD, Portmann BC, Johnson PJ, Williams R. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet. i:1985;1357-1359.
18. Johnson PJ, Zaman SN, Whire YS, Hayllar K, Metivier E, Williams R. Development of hepatoma in cirrhotic patients from low and intermediate incidence areas: final results of a 10 year prospective study. J Hepatol. 7:1988;S44.
19. Lin HJ, Shi N, Mizokami M, Hollinger FB. Polymerase chain reaction assay for hepatitis C virus RNA using single tube for reverse transcription and serial rounds of amplification with nested primer pairs. J Med Virol. 38:1992;220-225.
20. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, van Heuverswyn, et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol. 74:1993;1093-1102.
21. Vassiliadis T, Naoumov NV, Lau JYN, Johnson PJ, Williams R. Characteristics of hepatitis B virus (HBV) cirrhotic tissue predisposing to subsequent development of hepatocellular carcinoma. J Hepatol. 16:1992;S13.
22. Tarao K, Shimizu A, Ohkawa S, Harada M, Ito Y, Tamai S, et al. DEvelopment of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis. Gastroenterology. 103:1992;595-600.
23. Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann Intern Med. 116:1992;97-102.
24. Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Berthelot P, et al. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancer from HBsAg-negative patients: a study of a low endemic area. Hepatology. 17:1993;20-29.
25. De Mitri MS, Poussin K, Baccarini P, Pontisso P, D'Erico A, Simon N, et al. HCV-associated liver cancer without cirrhosis. Lancet. 345:1995;413-415.
26. Shiratori Y, Shina S, Imamura M, Kato N, Kanai F, Okudaira T, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B and C viral infection in Japan. Hepatology. 22:1995;1027-1033.
27. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology. 21:1995;650-655.
28. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, et al. Differential distribution of hepatiits C virus genotypes in patients with and without liver function abnormalities. Hepatology. 21:1995;285-290.
29. Bruno S, Silini E, Rossi S, Bono F, Borzio F, Leandro G, et al. HCV genotype 1b is a major risk factor for the development of hepatocellular carcinoma(HCC) in cirrhotic patients: a prospective study. J Hepatol. 23:1995;111. Suppl. 1.
30. Reid AE, Jeffers LJ, Reddy KR, Aiza J, Schiff ER, Dienstag JL, et al. Hepatitis C virus genotypes and hepatocellular carcinoma. Hepatology. 20:(4):1994;250A. Pt 2.
31. Bukh J, Miller RH, Kew MC, Purcell RH. Hepatitis C virus RNA in southern African blacks with hepatocellular carcinoma. Proc Natl Acad Sci USA. 90:1993;1848-1851.
32. Sugitani M, Inchauspe G, Shindo M, Prince AM. Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet. 339:1992;1018-1019.
33. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, et al. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet. 346:1995;1051-1055.
34. Mazzella G, Accogli E, Sottili S, Festi D, Orsini M, Salzetta A, et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol. 24:1996;141-147.